Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults.

Jaya GoswamiAbdullah H BaquiPablo A DoreskiGonzalo Perez MarcGilberto JimenezSalahuddin AhmedKhalequz ZamanChristopher J A DuncanMugen UjiieMika RämetLina Pérez-BrevaLan LanJiejun DuArchana KapoorShraddah MehtaJoanne E TomassiniWenmei HuangHonghong ZhouSonia K StoszekFrances PriddyNina LinNancy Le CamChristine A ShawKaren SlobodEleanor WilsonJacqueline M MillerRituparna Das

Published in: The Journal of infectious diseases (2024)

mRNA-1345 enhanced RSV-A and RSV-B nAbs and preF bAbs in adults (≥60 years) across various subgroups, including those at risk for severe disease, consistent with its demonstrated efficacy in the prevention of RSV disease.

Keyphrases

respiratory syncytial virus
respiratory tract
immune response
binding protein
early onset